跳至主要内容
临床试验/NCT01503346
NCT01503346已完成2 期

Taking Herbal Formula:DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage:A Clinical Control Trial Study

Changhua Christian Hospital1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2011年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
4
试验地点
1
主要终点
appetite score

研究概览

简要总结

Appetite loss is a severe and common symptom among late-stage cancer patients, and it causes great the anxiety for the patient's family. In TCM theory, the investigators call these patients are in block and repulsion condition. The investigators try to set a study to use the herbal medicine solution taken in frequent small amounts by cancer patients in late-stage to improve the appetite loss condition. Through this method, the investigators not only want to improve the quality of life of cancer patients in late-stage but also set a valuable treatment.

详细描述

Intervention group

    1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed and separated into four packages;
    1. each package was given to each patient four times a day (three time after meal and one time before sleep);
    1. each patient received the usual medication of the hospice ward at the same time;
    1. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day;
    1. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at the 1st day and the 6th day.

Control group

    1. each patient received the usual medication of the hospice ward during the trial interval;
    1. record the patients' score of receive pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day;
    1. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at at the 1st day and the 6th day.

Medicine DaHuang herbal abstract powder is produced by Sun Ten Pharmaceutical Co., Ltd, and it's product serial number: 276001. GanCao herbal abstract powder is also produced by Sun Ten Pharmaceutical Co., Ltd, and it's product serial number: 185645. Each herbal abstract powder is qualified with the data of HPLC to confirm each content and stability. The pharmaceutical company is qualified by Good Manufacturing Practice (GMP) certification in Taiwan.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Terminal cancer patients in hospice ward
  • Patients with appetite loss condition
  • Ages between 20 to 80 years old
  • No history of diabetes

排除标准

  • Entered the stage of dying patients
  • Receiving other traditional Chinese medicine

研究组 & 干预措施

herbal medicine

Experimental

Intervention group

    1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed and separated into four packages;
    1. each package was given to each patient four times a day (three time after meal and one time before sleep);
    1. each patient received the usual medication of the hospice ward at the same time;
    1. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day;
    1. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at the 1st day and the 6th day.

干预措施: DaHuang GanTsao Tang (Drug)

结局指标

主要结局

appetite score

时间窗: 6 days

The investigators detect the patients' appetite condition at the 1st,3rd and 6th day.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验